Virus-like particle immunotherapy or vaccines against SLC7A11 have been developed and shown to reduce the metastatic potential of breast cancer cells (Bolli et al., 2018; Donofrio et al., 2018; Ruiu et al., 2019). This evidence concerns the gene SLC7A11 and breast cancer.